| (HKD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 10.00B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2196.HK returned -16.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -11.7% |
| 1 year | -16.5% |
| 5 years | -62.3% |
| 10 years | -11.0% |
| All-time high | $71.10 (Jul 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2196.HK would be worth today ›Yes. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. paid 1 dividend over the past 12 months. The most recent was $0.45 per share on Jul 16, 2026. The dividend yield is 2.59%.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is part of the Healthcare sector.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has a market cap of 44.86B HKD, based on the latest quote.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is scheduled to report earnings on Aug 25, 2026.
